Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Agnosia 4Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pain, Postoperative 2Neoplasms 2Uveal Melanoma 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Rectal Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pain 1Opioid-Related Disorders 1Mucositis 1Mouth Neoplasms 1Melanoma 1Intra-abdominal Cancer 1Ileus 1Goiter 1Eye Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Chronic Pain 1Cancer Pain 1Brain Neoplasms 1

Interventions

Tramadol 1Oxycodone 1Hydrocodone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intra-abdominal Cancer × Tramadol × Clear all
NCT06232577 2026-05-14

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
170 enrolled

Intra-abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡